Effect of calcium dobesilate on platelet function

Thrombosis Research

Volumn 51, Issue 6, 1988, Pages 593-605

  Michal, M ^a   Gotti, C ^a  

^a Battelle Geneva Research Center   (Switzerland)

Author keywords

calcium dobesilate; cyclic AMP; platelet aggregation; release reaction

Indexed keywords

ADENOSINE; CYCLIC AMP; DOBESILATE CALCIUM; PROSTAGLANDIN E1; RADIOISOTOPE; THEOPHYLLINE;

CELL CULTURE; HUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ADENOSINE; ANIMAL; ARACHIDONIC ACID; ARACHIDONIC ACIDS; BENZENESULFONATES; CALCIUM DOBESILATE; COLLAGEN; CYCLIC AMP; DRUG INTERACTIONS; HAMSTERS; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDINS E; RABBITS; SEROTONIN; THEOPHYLLINE; THROMBIN;

EID: 0023729944     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(88)90143-0     Document Type: Article

References (31)

1. Calcium dobesilate reduces microvascular permeability to plasma proteins in diabetes mellitus
2. The effect of calcium dobesilate on albumin leakage of the conjuctival vessels
3. La résistance capillaire en ophtamologie
4. Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy
5. Effect of calcium dobesilate on blood hyperviscosity in cases of diabetic retinopathy
6. Hyperviscosity in diabetic retinopathy treated with Doxium (calcium dobesilate)
7. Platelets and venous thrombosis
8. Platelet hyperaggregation and increased plasma level of von Willebrand factor in diabetics with retinopathy
9. Platelet function in diabetes mellitus
10. Les modifications générales à l'origine de la rétinopathie diabétique
11. Plasma factors and platelet aggregation in diabetes mellitus
12. Beta-thromboglobulin in diabetes: relationships with blood glucose and fibronopeptide A
13. Inhibition of platelet aggregation under calcium dobesilate
14. Effect of Doxium on platelet functions in vitro and in vivo [abstr.]
15. Effect of calcium dobesilate treatment on haemostasis and serum lipids in diabetic patients
16. Effect of calcium dobesilate and its interaction with aspirin on thrombus formation in vivo
17. Aggregation of blood platelets by adenosine diphosphate and its reversal
18. Evidence that fibronectin is the collagen receptor on platelet membranes
19. Fibronectin and multiple interaction model for platelet collagen adhesion
20. Shape change and aggregation of blood platelets interaction between the effects of adenosine diphosphate 5-hydroxytryptamine and adrenaline
21. Cyclic adenosine 3′, 5′-monophosphate inhibits availability of arachidonate to prostaglandin synthetase in human platelet suspensions
22. Cyclic nucleotide-dependent protein kinases, I.V. widespread occurrence of cAMP-dependent protein kinase in various tissues and phyla of the animal kingdom
23. The role of prostacyclin in vascular tissue
24. Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia
25. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3′, 5′-cyclic monophosphate in platelets
26. 1 inhibits platelet aggregation by a pathway independent of adenosine 3′, 5′-monophosphate
27. Prevention of platelet deposition by ibuprofen and calcium dobesilate in expanded polyzetrafluoroethylene vascular grafts
28. Platelet function and diabetes mellitus
29. Platelet function in diabetes mellitus
30. Artherosclerosis in diabetes mellitus
31. Clinical approach to thrombosis and thromboembolism